Mumbai:Procter & Gamble Health Limited hasappointed Shashank Srowthy as Chief Financial Officer (CFO) of the Company and Additional (Executive) Director effective October 1, 2025. His appointment is subject to the allotment of a Director Identification Number by the Ministry of Corporate Affairs. Srowthy succeedsLokesh Chandak,who will step down asDirector & CFO effective close of business hours of September 30, 2025, as he will be moving onto his new assignment in P&G as Senior Director – Finance & Accounting, Feminine Care- Asia Pacific Enterprise Markets, Middle East and Africa. Procter & Gamble Health Limited was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to go public in the year 1981. Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. Read also:P&G Health partners with Indian Medical Association for launch of VitaM.I.N.D.S conclave
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!